Displaying drugs 7201 - 7225 of 13635 in total
Arcitumomab
Investigational
Tributyrin
Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid …
N-acetylhistamine
Experimental
Melanoma antigen recognized by T-cells 1
Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).
Investigational
Matched Description: … Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine ... Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery …
p-Chlorobenzoic acid
Experimental
Denibulin
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
Matched Description: … Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment …
AAV2/8.TBG.hARSB
Investigational
1-Ethyl-Pyrrolidine-2,5-Dione
Experimental
7-cyano-7-deazaguanine
Experimental
Taberminogene vadenovec
Taberminogene vadenovec (EG004) is a novel product consisting of a local delivery device and a gene-based medicine, being developed to prevent the blocking of veins and arteries that frequently occurs after vascular surgery. The initial target market is haemodialysis graft access surgery, a procedure in which patients whose kidneys have...
Investigational
Matched Description: … EG004 has completed a Phase II trial, this being the first part of the Phase II/III study for which it ... The initial target market is haemodialysis graft access surgery, a procedure in which patients whose ... kidneys have failed have a plastic tube grafted between blood vessels generally in their forearm so that …
3-Cyclohexyl-L-alanine
Experimental
Idronoxil
Idronoxil is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called signal transduction inhibitors.
Investigational
Matched Description: … Idronoxil is a substance that is being studied in the treatment of cancer. …
Inetetamab
Inetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.
Investigational
Matched Description: … It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and ... Inetetamab is a trastuzumab analog. …
Aluminium tristearate
Experimental
Vet approved
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP) is a synthetic analogue of meperidine. It is sold as a "synthetic heroin."
Experimental
Illicit
Matched Description: … It is sold as a "synthetic heroin." ... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP) is a synthetic analogue of meperidine. …
PLX51107
PLX51107 is a potent and selective inhibitor of the bromodomain and extraterminal (BET) protein family.[A257246,A257251] PLX51107 is under investigation in clinical trial NCT04022785 (PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome).
Investigational
Matched Description: … PLX51107 is a potent and selective inhibitor of the bromodomain and extraterminal (BET) protein family ... in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome). ... [A257246,A257251] PLX51107 is under investigation in clinical trial NCT04022785 (PLX51107 and Azacitidine …
(S)-Aspartimide
Experimental
ATYR-1940
Investigational
Deramciclane
Deramciclane (EGIS-3886) is used for the treatment of a number of anxiety disorders. Deramciclane differs from other anti anxiety medications in that it is not a benzodiazepine and so has a different structure and target. It antagonizes 5-HT2A receptors, agonizes 5-HT2C receptors, and functions as a GABA reuptake inhibitor.
Investigational
Matched Description: … Deramciclane (EGIS-3886) is used for the treatment of a number of anxiety disorders. ... Deramciclane differs from other anti anxiety medications in that it is not a benzodiazepine and so has ... a different structure and target. …
CX516
Investigational
Matuzumab
Matuzumab (formerly known as the experimental drug, EMD 72000) is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
Investigational
Matched Description: … It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth ... in cancer treatment. ... of blood vessels in malignancy, facilitating tumor growth and survival. …
N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea
Experimental
Matched Iupac: … 3-[(9bR)-5-oxo-1H,2H,3H,5H,9bH-benzo[a]pyrrolizin-9-yl]-1-(pyridin-2-yl)urea …
3,20-Pregnanedione
Experimental
Matched Iupac: … (1S,3aS,3bR,5aR,9aS,9bS,11aS)-1-acetyl-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-one …
Flurbiprofen axetil
Flurbiprofen axetil is under investigation in clinical trial NCT02043366 (Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients).
Investigational
Matched Description: … With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients). ... Flurbiprofen axetil is under investigation in clinical trial NCT02043366 (Effect of Butorphanol Combined …
APD791
APD791 is an oral anti-thrombotic drug candidate being evaluated in a Phase 1 clinical trial by Arena. APD791 is intended to lower the risk of arterial thrombosis by reducing the amplification of platelet aggregation, arterial constriction and intimal hyperplasia mediated by serotonin.
Investigational
Matched Description: … APD791 is an oral anti-thrombotic drug candidate being evaluated in a Phase 1 clinical trial by Arena …
Displaying drugs 7201 - 7225 of 13635 in total